MicroRNAs in diabetic macroangiopathy.

Area of Science:

• Endocrinology and Metabolism
• Molecular Biology
• Cardiovascular Research

Background:

• Diabetic macroangiopathy is a primary cause of mortality in diabetes patients.
• Both genetic and environmental factors influence diabetic macroangiopathy development.
• MicroRNAs (miRNAs) are emerging as key regulators in diabetes and its vascular complications.

Purpose of the Study:

• To review miRNA biogenesis and their specific functions in diabetic macroangiopathy.
• To summarize the role of miRNAs in various vascular diseases linked to diabetes, including atherosclerosis, peripheral artery disease, coronary artery disease, and cerebrovascular disease.
• To highlight the potential of miRNAs in advancing the diagnosis, prevention, and treatment of diabetic macroangiopathy.

Main Methods:

• Literature review focusing on the role of microRNAs in diabetic macroangiopathy.
• Synthesis of current knowledge on miRNA biogenesis and function.
• Analysis of miRNA involvement in specific diabetic vascular complications.

Main Results:

• MicroRNAs play significant roles in the initiation and progression of diabetic macroangiopathy.
• Dysregulation of specific miRNAs is implicated in atherosclerosis, peripheral artery disease, coronary artery disease, and cerebrovascular disease.
• miRNAs offer potential as biomarkers and therapeutic targets for diabetic vascular complications.

Conclusions:

• MicroRNAs are critical in the pathogenesis of diabetic macroangiopathy.
• Understanding miRNA functions provides new avenues for research and clinical applications.
• Targeting miRNAs may lead to improved diagnosis, prevention, and treatment strategies for diabetic macroangiopathy.